BIOTECH ACQUISITION COMPANY
Updated 27 days ago
545 West 25th Street, 20th Floor New York, NY, USA 10001
Biotech Acquisition Company is a blank check company, incorporated as a Cayman Islands exempted company, formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses. BAC believes that a partnership with target companies focused in the healthcare sector will complement the background and expertise of SPRIM Global Investments (a global investment firm in the life sciences and healthcare industries), an affiliate of and the management team behind BAC. BAC is led by Dr. Michael Shleifer, its CEO and chairman. The Class A Ordinary Shares and Warrants of BAC trade on the NASDAQ Capital Market under the symbols "BIOT" and "BIOTW," respectively.
Associated domains: bioacquisitioncompany.com, biotechacquisitioncompany.com